[Federal Register Volume 80, Number 88 (Thursday, May 7, 2015)]
[Notices]
[Page 26236]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-10990]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent To Grant Partially Exclusive Patent License;
Epitracker, LLC
AGENCY: Department of the Navy, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of the Navy hereby gives notice of its intent
to grant to Epitracker, LLC, a revocable, nonassignable, partially
exclusive license in the United States to practice the Government-Owned
inventions described in U.S. Patent Application No. 14/591660--``Use of
heptadecanoic acid (C17:0) to detect risk of and treat
hyperferritinemia and metabolic syndrome''.
DATES: Anyone wishing to object to the grant of this license must file
written objections along with supporting evidence, if any, no later
than May 22, 2015.
ADDRESSES: Written objections are to be filed with the Office of
Research and Technology Applications, Space and Naval Warfare Systems
Center Pacific, Code 72120, 53560 Hull St., Bldg. A33 Room 2531, San
Diego, CA 92152-5001.
FOR FURTHER INFORMATION CONTACT: Brian Suh, Office of Research and
Technology Applications, Space and Naval Warfare Systems Center
Pacific, Code 72120, 53560 Hull St., Bldg. A33 Room 2531, San Diego, CA
92152-5001, telephone 619-553-5118, E-Mail: [email protected].
Authority: 35 U.S.C. 207, 37 CFR part 404.
Dated: May 1, 2015.
N.A. Hagerty-Ford,
Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register
Liaison Officer.
[FR Doc. 2015-10990 Filed 5-6-15; 8:45 am]
BILLING CODE 3810-FF-P